ClinicalTrials.Veeva

Menu

Investigation of the Relationship Between Salivary Histatine-5 Level and Vaginal Candidiasis in Women

U

Usak State Hospital

Status

Completed

Conditions

Candidiasis
Vaginal Infection

Treatments

Other: salivary sample

Study type

Observational

Funder types

Other

Identifiers

NCT05044156
Usak State Hospital

Details and patient eligibility

About

The low Histatine-5 (HST-5) level of the saliva can lead to vaginal candidiasis. Because HST-5 level in the saliva can effect vaginal Ph, flora and local defence mechanisms.

Histatine-5 is secreted in the parotis and submandibular glands. İt riches histidine amino ascid and have antifungal activity. Salivary proteins and their plasma levels were found as similar in the literature.

Full description

Women with regularly menstrual cycle will enroll in the study than will separate two groups:

Study group: women with vaginal candidiasis ( diagnosed by clinic and lab.)

Control group: women ( not have any vaginal infections candida and others)

Saliva samples will be taken from two groups than HST-5 level will be analyzed. Finally HST-5 levels of the two groups will be compared .

Women with diabetes, immun deficiency, pregnancy, virgin, menopausal period , premature ovarian failure will be excluded.

Enrollment

90 patients

Sex

Female

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: women with regularly menstrual cycle , diagnosed candidal vaginosis and not have any vaginal infection.

Exclusion Criteria: diabetes, immun deficiency, menopause, premature ovarian failure, pregnancy, virgin

Trial design

90 participants in 2 patient groups

Case group
Description:
vaginal candidiasis
Treatment:
Other: salivary sample
Control group
Description:
healty women
Treatment:
Other: salivary sample

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems